Cargando…

Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study

We aimed to describe the variation of hemostasis proteins in children with bacterial infections due to different pathogens (Neisseria meningitidis, Streptococcus pneumoniae, Staphylococcus aureus, and group A streptococcus [GAS]) and to study hemostasis proteins in relation to mortality. DESIGN: Pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagedoorn, Nienke N., Boeddha, Navin P., Kohlfuerst, Daniela S., Anderson, Suzanne, Carrol, Enitan D., Agapow, Paul, van der Flier, Michiel, Hazelzet, Jan, Herberg, Jethro, Kuijpers, Taco, Levin, Michael, Martinon-Torres, Federico, van Rijswijk, Angelique, Schlapbach, Luregn J., Vermont, Clementien, Zenz, Werner, Dik, Willem A., Driessen, Gertjan, Emonts, Marieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708080/
https://www.ncbi.nlm.nih.gov/pubmed/36044313
http://dx.doi.org/10.1097/PCC.0000000000003056
_version_ 1784840843825250304
author Hagedoorn, Nienke N.
Boeddha, Navin P.
Kohlfuerst, Daniela S.
Anderson, Suzanne
Carrol, Enitan D.
Agapow, Paul
van der Flier, Michiel
Hazelzet, Jan
Herberg, Jethro
Kuijpers, Taco
Levin, Michael
Martinon-Torres, Federico
van Rijswijk, Angelique
Schlapbach, Luregn J.
Vermont, Clementien
Zenz, Werner
Dik, Willem A.
Driessen, Gertjan
Emonts, Marieke
author_facet Hagedoorn, Nienke N.
Boeddha, Navin P.
Kohlfuerst, Daniela S.
Anderson, Suzanne
Carrol, Enitan D.
Agapow, Paul
van der Flier, Michiel
Hazelzet, Jan
Herberg, Jethro
Kuijpers, Taco
Levin, Michael
Martinon-Torres, Federico
van Rijswijk, Angelique
Schlapbach, Luregn J.
Vermont, Clementien
Zenz, Werner
Dik, Willem A.
Driessen, Gertjan
Emonts, Marieke
author_sort Hagedoorn, Nienke N.
collection PubMed
description We aimed to describe the variation of hemostasis proteins in children with bacterial infections due to different pathogens (Neisseria meningitidis, Streptococcus pneumoniae, Staphylococcus aureus, and group A streptococcus [GAS]) and to study hemostasis proteins in relation to mortality. DESIGN: Preplanned analysis in prospective cohort study. SETTING: Hospitals in five European countries (Austria, The Netherlands, Spain, Switzerland, and the United Kingdom). PATIENTS: Admitted children (2012–2016) with community-acquired infections due to meningococci (n = 83), pneumococci (n = 64), S. aureus (n = 50), and GAS (n = 44) with available serum samples collected less than 48 hours after admission. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Fibronectin, plasminogen activator inhibitor type 1 (PAI-1), thrombomodulin, and a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS-13) were measured in serum in 2019–2020. Additionally, von Willebrand factor, protein C, protein S, and factor IX were measured in citrate plasma available from a subset of patients. Outcome measures included in-hospital mortality and disease severity (need for ventilation/inotropes, Pediatric Index of Mortality score). Of 241 children, 21 (8.7%) died and 177 (73.5%) were admitted to PICU. Mortality rate was similar for the pathogen groups. Levels of fibronectin and thrombomodulin differed for the different pathogens (p < 0.05). Fibronectin levels were lower in GAS infections than in S. pneumoniae and S. aureus infections but did not differ from meningococcal infections. Thrombomodulin levels in meningococcal infections were higher than in S. aureus and pneumococcal infections. Overall, the area under the curve for mortality was 0.81 (95% CI, 0.70–0.92) for thrombomodulin and 0.78 (95% CI, 0.69–0.88) for ADAMTS-13. The association of each hemostasis protein did not vary across pathogens for any of the outcome measures. CONCLUSIONS: Hemostatic disturbances in childhood bacterial infections are not limited to meningococcal sepsis but occur with a comparable severity across nonmeningococcal infections. High thrombomodulin and high ADAMTS-13 had good discriminative ability for mortality. Our results emphasize the importance of hemostatic disturbances in meningococcal and nonmeningococcal pediatric bacterial infections.
format Online
Article
Text
id pubmed-9708080
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-97080802022-12-06 Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study Hagedoorn, Nienke N. Boeddha, Navin P. Kohlfuerst, Daniela S. Anderson, Suzanne Carrol, Enitan D. Agapow, Paul van der Flier, Michiel Hazelzet, Jan Herberg, Jethro Kuijpers, Taco Levin, Michael Martinon-Torres, Federico van Rijswijk, Angelique Schlapbach, Luregn J. Vermont, Clementien Zenz, Werner Dik, Willem A. Driessen, Gertjan Emonts, Marieke Pediatr Crit Care Med Online Clinical Investigations We aimed to describe the variation of hemostasis proteins in children with bacterial infections due to different pathogens (Neisseria meningitidis, Streptococcus pneumoniae, Staphylococcus aureus, and group A streptococcus [GAS]) and to study hemostasis proteins in relation to mortality. DESIGN: Preplanned analysis in prospective cohort study. SETTING: Hospitals in five European countries (Austria, The Netherlands, Spain, Switzerland, and the United Kingdom). PATIENTS: Admitted children (2012–2016) with community-acquired infections due to meningococci (n = 83), pneumococci (n = 64), S. aureus (n = 50), and GAS (n = 44) with available serum samples collected less than 48 hours after admission. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Fibronectin, plasminogen activator inhibitor type 1 (PAI-1), thrombomodulin, and a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS-13) were measured in serum in 2019–2020. Additionally, von Willebrand factor, protein C, protein S, and factor IX were measured in citrate plasma available from a subset of patients. Outcome measures included in-hospital mortality and disease severity (need for ventilation/inotropes, Pediatric Index of Mortality score). Of 241 children, 21 (8.7%) died and 177 (73.5%) were admitted to PICU. Mortality rate was similar for the pathogen groups. Levels of fibronectin and thrombomodulin differed for the different pathogens (p < 0.05). Fibronectin levels were lower in GAS infections than in S. pneumoniae and S. aureus infections but did not differ from meningococcal infections. Thrombomodulin levels in meningococcal infections were higher than in S. aureus and pneumococcal infections. Overall, the area under the curve for mortality was 0.81 (95% CI, 0.70–0.92) for thrombomodulin and 0.78 (95% CI, 0.69–0.88) for ADAMTS-13. The association of each hemostasis protein did not vary across pathogens for any of the outcome measures. CONCLUSIONS: Hemostatic disturbances in childhood bacterial infections are not limited to meningococcal sepsis but occur with a comparable severity across nonmeningococcal infections. High thrombomodulin and high ADAMTS-13 had good discriminative ability for mortality. Our results emphasize the importance of hemostatic disturbances in meningococcal and nonmeningococcal pediatric bacterial infections. Lippincott Williams & Wilkins 2022-08-31 2022-12 /pmc/articles/PMC9708080/ /pubmed/36044313 http://dx.doi.org/10.1097/PCC.0000000000003056 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Online Clinical Investigations
Hagedoorn, Nienke N.
Boeddha, Navin P.
Kohlfuerst, Daniela S.
Anderson, Suzanne
Carrol, Enitan D.
Agapow, Paul
van der Flier, Michiel
Hazelzet, Jan
Herberg, Jethro
Kuijpers, Taco
Levin, Michael
Martinon-Torres, Federico
van Rijswijk, Angelique
Schlapbach, Luregn J.
Vermont, Clementien
Zenz, Werner
Dik, Willem A.
Driessen, Gertjan
Emonts, Marieke
Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study
title Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study
title_full Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study
title_fullStr Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study
title_full_unstemmed Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study
title_short Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study
title_sort hemostasis proteins in invasive meningococcal and nonmeningococcal infections: a prospective multicenter study
topic Online Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708080/
https://www.ncbi.nlm.nih.gov/pubmed/36044313
http://dx.doi.org/10.1097/PCC.0000000000003056
work_keys_str_mv AT hagedoornnienken hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT boeddhanavinp hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT kohlfuerstdanielas hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT andersonsuzanne hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT carrolenitand hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT agapowpaul hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT vanderfliermichiel hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT hazelzetjan hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT herbergjethro hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT kuijperstaco hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT levinmichael hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT martinontorresfederico hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT vanrijswijkangelique hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT schlapbachluregnj hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT vermontclementien hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT zenzwerner hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT dikwillema hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT driessengertjan hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy
AT emontsmarieke hemostasisproteinsininvasivemeningococcalandnonmeningococcalinfectionsaprospectivemulticenterstudy